文献速递消化内镜消化道肿瘤与早癌

比较注水交换、注水浸泡与注气法结肠镜检查腺瘤检出率的前瞻性多中心随机对照试验

Prospective multicenter randomized controlled trial comparing adenoma detection rate in colonoscopy using water exchange, water immersion, and air insufflation.
PubMed 文献 · Gastrointest Endosc · 2016-12-15

在台湾两家医院开展的前瞻性随机对照试验,将651例患者按1:1:1随机分为注水交换(WE)、注水浸泡(WI)和注气(AI)三组,主要终点为腺瘤检出率(ADR)。WE组ADR为49.8%,显著高于AI组的37.8%(P=.016);WI组为40.6%,与WE组无差异,与AI组相当。

要点

  • 注水交换组腺瘤检出率为49.8%,显著高于注气组的37.8%(P=.016)。
  • 注水浸泡组腺瘤检出率为40.6%,与注水交换组无差异,与注气组相当。
  • 注水交换组插入时间更长、清洁评分更高,但每次阳性结肠镜的腺瘤数和退镜时间与注气组相似。

核心结论

  • 证实注水交换而非注水浸泡可提高腺瘤检出率,进一步强化了观察结果的有效性。
  • 注水交换显著提高了丙泊酚镇静患者的腺瘤检出率。
  • 结果差异支持评估注水交换在结直肠癌预防中的作用。
  • 各研究组每次阳性结肠镜的腺瘤数和退镜时间相似,提示各组的退镜检查充分。

研究设计与样本

  • 前瞻性研究,在台湾南部大林慈济医院和东部花莲慈济医院开展。
  • 患者按1:1:1随机分配至注水交换、注水浸泡或注气组,并按3名研究结肠镜医师分层。
  • 2013年7月至2015年12月共招募651例患者,每组217例。
  • 主要终点为腺瘤检出率,定义为至少检出1个任意大小腺瘤的患者比例。

主要发现

  • 总体腺瘤检出率:注水交换组49.8%(95%CI 43.2%-56.4%),注气组37.8%(95%CI 31.6%-44.4%),注水浸泡组40.6%(95%CI 34.2%-47.2%)。
  • 与注气组相比,注水交换组腺瘤检出率显著升高(P=.016)。
  • 注水浸泡组与注水交换组之间无差异;注水浸泡组与注气组腺瘤检出率相当。
  • 与注气组相比,注水交换组插入时间更长、清洁评分更高,但每次阳性结肠镜的腺瘤数和带息肉切除的退镜时间相似。
  • 亚组分析发现注水交换显著提高了丙泊酚镇静患者的腺瘤检出率。

关键数值与推荐

  • 腺瘤检出率总体达到质量标准:注水交换49.8%(95%CI 43.2%-56.4%),注气37.8%(95%CI 31.6%-44.4%),注水浸泡40.6%(95%CI 34.2%-47.2%)。
  • 与注气组相比,注水交换组腺瘤检出率显著升高(P=.016)。
  • 注水交换(对比注气)、年龄≥50岁、结肠镜检查指征、无既往结肠镜检查史和退镜时间>8分钟为腺瘤检出率升高的显著预测因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Adenoma detection rate (ADR), defined as the proportion of patients with at least one adenoma of any size, is a quality indicator. We tested the hypothesis that water exchange (WE) improves ADR but water immersion (WI) has no adverse effect on ADR compared with air insufflation (AI). METHODS: A prospective study was conducted at the Dalin Tzu Chi Hospital in southern Taiwan and the Hualien Tzu Chi Hospital in eastern Taiwan on patients randomly assigned to WE, WI, or AI with stratification by the 3 study colonoscopists. The primary outcome was ADR. RESULTS: From July 2013 to December 2015, 651 patients were recruited and randomized into 3 groups with a 1:1:1 ratio (217 patients per group). Overall, ADR met quality standards: WE 49.8% (95% CI, 43.2%-56.4%), AI 37.8% (95% CI, 31.6%-44.4%), and WI 40.6% (95% CI, 34.2%-47.2%). Compared with AI, WE significantly increased ADR (P = .016). There was no difference between WI and WE. ADRs of WI and AI were comparable. Compared with AI, WE confirmed a longer insertion time, higher cleanliness score, but similar adenoma per positive colonoscopy (APPC) and withdrawal time with polypectomy. Subgroup analysis found WE significantly increased ADR in propofol-sedated patients. Multivariate generalized linear mixed model analysis revealed that age ≥50 years, WE (vs AI), colonoscopy indication, no previous history of colonoscopy, and withdrawal time >8 minutes were significant predictors of increased ADR. CONCLUSIONS: Confirmation of prior reports showing WE, but not WI, increased ADR further strengthened the validity of our observations. WE significantly increased ADR in propofol-sedated patients. The outcome differences justify assessment of the role of WE in colorectal cancer prevention. Similar APPC and withdrawal times suggest that adequate inspection was performed on colonoscope withdrawal in each of the study arms. (Clinical trial registration number: NCT01894191.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Hsieh YH, Tseng CW, Hu CT, et al. Prospective multicenter randomized controlled trial comparing adenoma detection rate in colonoscopy using water exchange, water immersion, and air insufflation. Gastrointest Endosc. 2016. PMID: 27988288. doi:10.1016/j.gie.2016.12.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。